All Stories
- ArticlePolypharmacy & Pharmacists; Multicenter Prospective Study Demonstrates Benefits of Interventions
- ArticlePain accompanying photoimmunotherapy for head and neck cancer
- ArticleImpact of lenvatinib-induced proteinuria and renal dysfunction in patients with thyroid cancer
- ArticleMulticentre prospective observational study on community pharmacist interventions to reduce inappropriate medications
- ArticleNeeds of chemotherapy regimen checks procedure: from the survey on chemotherapy regimen checks performed by pharmacists in hospitals other than designated cancer hospitals in Japan
- ArticleMO8-5 Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer
- ArticleDrug cost savings resulting from the outpatient pharmacy services collaborating with oncologists at outpatient clinics
- ArticleGrade 3 infusion-related reaction because of cetuximab administered with 5-fluorouracil and cisplatin chemotherapy for a recurrent and metastatic head and neck cancer patient who received chlorpheniramine 5 mg, dexamethasone 13.2 mg, and aprepitant 125...
- ArticleImpact of outpatient pharmacy interventions on management of thyroid patients receiving lenvatinib
- ArticleEvaluation of Acute Kidney Injury Associated With Anticancer Drugs Used in Gastric Cancer in the Japanese Adverse Drug Event Report Database
- ArticleA nationwide survey of hospital pharmacist interventions to improve polypharmacy for patients with cancer in palliative care in Japan
- ArticleAnalyses of Respiratory Depression Associated with Opioids in Cancer Patients Based on the Japanese Adverse Drug Event Report Database
- ArticleCurrent Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database
- ArticleA nationwide survey of community pharmacist contributions to polypharmacy in opioid-using and non-using cancer patients in Japan
- ArticleImpact of outpatient pharmacy services collaborating with oncologists at an outpatient clinic for outpatient chemotherapy prescription orders
- ArticlePredictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
- ArticleImpact of pharmacy collaborating services in an outpatient clinic on improving adverse drug reactions in outpatient cancer chemotherapy
- ArticleCurrent status of drug vial optimization use to prevent waste associated with injectable anticancer agents
- ArticleComparative evaluation of a website for drug incompatibility
- ArticleESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe
- ArticleSPS-3Impact of clinical pharmacists collaborating with oncologists in outpatient cancer chemotherapy on cost of chemotherapy
- ArticleRetrospective analysis of premedication, glucocorticosteroids, and H1-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
- ArticleOpportunities to significantly reduce expenditure associated with cancer drugs
- ArticleEvaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan
- ArticleIncidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
- ArticleThe impact of pharmacist certification on the quality of chemotherapy in Japan
- ArticleEvaluation of the anticoagulant effect and timing of the concomitant use of S-1 and warfarin
- ArticleP2-088Impact of pharmacist outpatient interventions on management of Lenvatinib for thyroid cancer patients
- ArticlePlaces to Managing Medicines Patients Brought in Hospital: Which is Better Central Pharmacy or Hospital Wards?
- ArticleChemotherapy regimen checks performed by pharmacists contribute to safe administration of chemotherapy
- ArticleP2-9-52Retrospective analysis of anti-allergy prophylaxis for infusion reactions of cetuximab in head and neck cancer patients
- ArticleP2-9-11Retrospective analysis of emergency hospital admission due to chemoradiotherapy for head and neck cancer patients
- Articleソラフェニブによる手足症候群に対する尿素配合軟膏の予防投与の有効性
- ArticleO1-18-6CETUXIMAB INFUSION REACTIONS IN JAPANESE HEAD AND NECK CANCER PATIENTS
- Article998PINCIDENCE AND RISK FACTORS OF HYPOMAGNESEMIA IN HEAD AND NECK CANCER PATIENTS TREATED WITH CETUXIMAB
- ArticleEvaluation of the impact of a flowchart-type leaflet for cancer inpatients
- ArticleP1-100 * SURVEY OF PHARMACISTS' INVOLVEMENT IN CANCER TREATMENT IN CANCER MEDICINE COOPERATION BASE AND GENERAL HOSPITALS
- ArticleP1-101 * ACTUAL SITUATION AND MULTIFACTORIAL ANALYSIS OF STANDARD CANCER CHEMOTHERAPY REGIMEN USE IN JAPAN
- ArticleO1-100 * EVALUATION OF PROPHYLACTIC TETRACYCLINES USE IN CETUXIMAB CHEMOTHERAPY FOR HEAD AND NECK CANCER
- ArticleSurvey of Pharmacists Involved in Cancer Treatment in Cancer Medicine Cooperation Base Hospitals
- ArticleEvaluation of nausea and vomiting in radiation plus concurrent weekly cisplatin (weekly CDDP+RT) without prophylactic aprepitant in head and neck cancer
- ArticleRisk Factor of the Hand/foot Skin Reaction Induced by Sorafenib in Patients with Advanced Hepatocellular Carcinoma
- ArticleLB023-SUN A NON-RANDOMIZED COMPARISON OF TUBE FEEDING OF ELEMENTAL DIET AND LOW RESIDUE DIET IN HEAD AND NECK CANCER PATIENTS DURING CONCURRENT CHEMORADIOTHERAPY
- ArticleAdherence in Use of Oral Antibiotics for Fever in Outpatient Docetaxel Chemotherapy
- ArticleSurvey on Opioid and Psychotic Use by Cancer Patients
- ArticleEvaluation of Improvement of Adherence Following Pharmacist Intervention for Hand/Foot Skin Reactions Induced by Sorafenib